American International Group, Inc. Assembly Biosciences, Inc. Transaction History

American International Group, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.8 - $4.56 $67,966 - $81,560	-17,886 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$4.33 - $6.63 $203 - $311	47 Added 0.26%	17,886 $82,000
Q4 2020 Feb 12, 2021	SELL	$4.87 - $17.29 $2,493 - $8,852	-512 Reduced 2.79%	17,839 $108,000
Q3 2020 Nov 04, 2020	SELL	$15.08 - $27.04 $6,288 - $11,275	-417 Reduced 2.22%	18,351 $302,000
Q2 2020 Aug 12, 2020	BUY	$14.57 - $23.96 $28,367 - $46,650	1,947 Added 11.57%	18,768 $438,000
Q1 2020 May 04, 2020	BUY	$10.27 - $21.23 $24,750 - $51,164	2,410 Added 16.72%	16,821 $249,000
Q4 2019 Feb 05, 2020	BUY	$8.36 - $23.81 $1,061 - $3,023	127 Added 0.89%	14,411 $295,000
Q3 2019 Nov 08, 2019	SELL	$9.83 - $14.82 $973 - $1,467	-99 Reduced 0.69%	14,284 $140,000
Q2 2019 Aug 13, 2019	BUY	$12.9 - $20.8 $12,616 - $20,342	978 Added 7.3%	14,383 $194,000
Q1 2019 May 06, 2019	SELL	$17.7 - $24.93 $7,699 - $10,844	-435 Reduced 3.14%	13,405 $264,000
Q4 2018 Feb 13, 2019	SELL	$19.05 - $36.45 $2,019 - $3,863	-106 Reduced 0.76%	13,840 $313,000
Q3 2018 Nov 09, 2018	BUY	$34.41 - $44.23 $99,307 - $127,647	2,886 Added 26.09%	13,946 $518,000
Q2 2018 Aug 08, 2018	BUY	$39.21 - $50.29 $25,721 - $32,990	656 Added 6.31%	11,060 $434,000
Q1 2018 May 07, 2018	SELL	$41.7 - $64.16 $18,723 - $28,807	-449 Reduced 4.14%	10,404 $511,000
Q4 2017 Feb 09, 2018	BUY	$28.58 - $49.91 $41,441 - $72,369	1,450 Added 15.42%	10,853 $491,000
Q3 2017 Nov 09, 2017	BUY	$23.08 - $34.92 $217,021 - $328,352	9,403	9,403 $328,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.